Intraperitoneal Chemotherapy Shows Highly Uncertain Survival Benefits in Gastric Cancer With Peritoneal Risk
A comprehensive Cochrane review of nine randomized controlled trials involving 829 participants evaluated intraperitoneal chemotherapy (IPC) as either prophylactic therapy ...
Read moreDetails